Work

1335P Phase Ib study to evaluate the safety and tolerability of osimertinib with ipilimumab in EGFRm NSCLC

Year: 2023

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.2368

Authors: S. Puri, S. Patel, K. Kerrigan, A. Chalmers, S. George, P. Hammon, E. Loertscher, H. Lee, K. Boucher, W. Akerley

Institutions: Huntsman Cancer Institute, St. George's University, University of Utah

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387810714

FWCI:

Cites: 1

Cited by:

Related to: 10